Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

PAR-1 contributes to the innate immune response during viral infection
Silvio Antoniak, … , Ursula Rauch, Nigel Mackman
Silvio Antoniak, … , Ursula Rauch, Nigel Mackman
Published February 8, 2013
Citation Information: J Clin Invest. 2013;123(3):1310-1322. https://doi.org/10.1172/JCI66125.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 17

PAR-1 contributes to the innate immune response during viral infection

  • Text
  • PDF
Abstract

Coagulation is a host defense system that limits the spread of pathogens. Coagulation proteases, such as thrombin, also activate cells by cleaving PARs. In this study, we analyzed the role of PAR-1 in coxsackievirus B3–induced (CVB3-induced) myocarditis and influenza A infection. CVB3-infected Par1–/– mice expressed reduced levels of IFN-β and CXCL10 during the early phase of infection compared with Par1+/+ mice that resulted in higher viral loads and cardiac injury at day 8 after infection. Inhibition of either tissue factor or thrombin in WT mice also significantly increased CVB3 levels in the heart and cardiac injury compared with controls. BM transplantation experiments demonstrated that PAR-1 in nonhematopoietic cells protected mice from CVB3 infection. Transgenic mice overexpressing PAR-1 in cardiomyocytes had reduced CVB3-induced myocarditis. We found that cooperative signaling between PAR-1 and TLR3 in mouse cardiac fibroblasts enhanced activation of p38 and induction of IFN-β and CXCL10 expression. Par1–/– mice also had decreased CXCL10 expression and increased viral levels in the lung after influenza A infection compared with Par1+/+ mice. Our results indicate that the tissue factor/thrombin/PAR-1 pathway enhances IFN-β expression and contributes to the innate immune response during single-stranded RNA viral infection.

Authors

Silvio Antoniak, A. Phillip Owens III, Martin Baunacke, Julie C. Williams, Rebecca D. Lee, Alice Weithäuser, Patricia A. Sheridan, Ronny Malz, James P. Luyendyk, Denise A. Esserman, JoAnn Trejo, Daniel Kirchhofer, Burns C. Blaxall, Rafal Pawlinski, Melinda A. Beck, Ursula Rauch, Nigel Mackman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 Total
Citations: 1 6 8 7 11 12 4 7 5 11 4 5 7 88
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (88)

Title and authors Publication Year
Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular content
Beetler DJ, Giresi P, Di Florio DN, Fliess JJ, McCabe EJ, Watkins MM, Xu V, Auda ME, Bruno KA, Whelan ER, Kocsis SP, Edenfield BH, Walker SA, Macomb LP, Keegan KC, Jain A, Morales-Lara AC, Chekuri I, Hill AR, Farres H, Wolfram J, Behfar A, Stalboerger PG, Terzic A, Cooper LT Jr, Fairweather D
Frontiers in Immunology 2025
Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors
Lotke R, Petersen M, Sauter D
Viruses 2024
Unveiling the Role of PAR 1: A Crucial Link with Inflammation in Diabetic Subjects with COVID-19
Singh R, Singh V, Ahmad MA, Pasricha C, Kumari P, Singh TG, Kaur R, Mujwar S, Wani TA, Zargar S
Pharmaceuticals 2024
Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis.
Callon D, Glenet M, Lebreil AL, Heng L, Bouland N, Fichel C, Fornes P, Andreoletti L, Berri F
PLoS pathogens 2024
The Role of ACE2 Receptor and Its Polymorphisms in COVID-19 Infection and Severity and Its Association with Lipid Profile, Thrombin, and D-Dimer Levels in Iraqi Patients: A Cross-Sectional Study.
Hatem BA, Jabir FA
Biochemical Genetics 2024
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling
Jannati S, Patnaik R, Banerjee Y
International Journal of Molecular Sciences 2024
STAT3 Increases CVB3 Replication and Acute Pancreatitis and Myocarditis Pathology via Impeding Nuclear Translocation of STAT1 and Interferon-Stimulated Gene Expression
Liang T, Zhang Z, Bai Z, Xu L, Xu W
International Journal of Molecular Sciences 2024
Immune mechanisms of group B coxsackievirus induced viral myocarditis
Zhang Y, Zhou X, Chen S, Sun X, Zhou C
Virulence 2023
An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation
Ryan TA, O\u2019Neill LA
Cells 2023
Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure
Yip F, Lai B, Yang D
International journal of molecular sciences 2023
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
Ryan TA, Hooftman A, Rehill AM, Johansen MD, Brien EC, Toller-Kawahisa JE, Wilk MM, Day EA, Weiss HJ, Sarvari P, Vozza EG, Schramm F, Peace CG, Zotta A, Miemczyk S, Nalkurthi C, Hansbro NG, McManus G, O\u2019Doherty L, Gargan S, Long A, Dunne J, Cheallaigh CN, Conlon N, Carty M, Fallon PG, Mills KH, Creagh EM, Donnell JS, Hertzog PJ, Hansbro PM, McLoughlin RM, Wygrecka M, Preston RJ, Zasłona Z, Neill LA
Nature Communications 2023
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
Koudriavtseva T, Lorenzano S, Cellerino M, Truglio M, Fiorelli M, Lapucci C, D\u2019Agosto G, Conti L, Stefanile A, Zannino S, Filippi MM, Cortese A, Piantadosi C, Maschio M, Maialetti A, Galiè E, Salvetti M, Inglese M
Frontiers in immunology 2023
New insight into the agonism of protease-activated receptors as an immunotherapeutic strategy.
Jiang Y, Lu L
The Journal of biological chemistry 2023
Reconstituted extracellular vesicles from human platelets decrease viral myocarditis in mice
Beetler DJ, Bruno KA, Watkins MM, Xu V, Chekuri I, Giresi P, Di Florio DN, Whelan ER, Edenfield BH, Walker SA, Morales-Lara AC, Hill AR, Jain A, Auda ME, Macomb LP, Shapiro KA, Keegan KC, Wolfram J, Behfar A, Stalboerger PG, Terzic A, Farres H, Cooper LT Jr, Fairweather D
Small (Weinheim an Der Bergstrasse, Germany) 2023
Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling
Zelaya H, Grunz K, Nguyen TS, Habibi A, Witzler C, Reyda S, Gonzalez-Menendez I, Quintanilla-Martinez L, Bosmann M, Weiler H, Ruf W
Blood 2023
Activated Protein C Protects against Murine Contact Dermatitis by Suppressing Protease-Activated Receptor 2
M Xue, H Lin, R Zhao, C Fryer, L March, C Jackson
International journal of molecular sciences 2022
The enzymes in COVID-19: A review
M Alves, L Mahnke, T Macedo, T dos Santos Silva, L Junior
Biochimie 2022
Hemostatic system and COVID-19 crosstalk: A review of the available evidence
Wifi MN, Morad MA, El Sheemy R, Abdeen N, Afify S, Abdalgaber M, Abdellatef A, Zaghloul M, Alboraie M, El-Kassas M
World Journal of Methodology 2022
Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
Ryan TA, O'Neill LA
European Journal of Immunology 2022
Platelet in thrombo-inflammation: Unraveling new therapeutic targets
Sharma S, Tyagi T, Antoniak S
Frontiers in immunology 2022
Platelets in COVID-19 disease: friend, foe, or both?
Smęda M, Hosseinzadeh Maleki E, Pełesz A, Chłopicki S
Pharmacological reports : PR 2022
Cytotoxic CD8+ T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation
Friebel J, Witkowski M, Wegner M, Blöbaum L, Lammel S, Schencke PA, Jakobs K, Puccini M, Reißner D, Steffens D, Moos V, Schutheiss HP, Landmesser U, Rauch U
Cells 2022
Platelet-Mediated NET Release Amplifies Coagulopathy and Drives Lung Pathology During Severe Influenza Infection
SJ Kim, A Carestia, B McDonald, AZ Zucoloto, H Grosjean, RP Davis, M Turk, V Naumenko, S Antoniak, N Mackman, MS Abdul-Cader, MF Abdul-Careem, MD Hollenberg, CN Jenne
Frontiers in immunology 2021
Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019
S Subramaniam, W Ruf, M Bosmann
British Journal of Pharmacology 2021
Cell type-specific roles of PAR1 in Coxsackievirus B3 infection
MF Bode, CM Schmedes, GJ Egnatz, V Bharathi, YM Hisada, D Martinez, T Kawano, A Weithauser, L Rosenfeldt, U Rauch, JS Palumbo, S Antoniak, N Mackman
Scientific Reports 2021
Host Components That Modulate the Disease Caused by hMPV
NM Gálvez, CA Andrade, GA Pacheco, JA Soto, V Stranger, T Rivera, AE Vásquez, AM Kalergis
Viruses 2021
The role of protease-activated receptor 1 signaling in CD8 T cell effector functions
H Chen, M Smith, J Herz, T Li, R Hasley, CL Saout, Z Zhu, J Cheng, A Gronda, JA Martina, PM Irusta, T Karpova, DB McGavern, M Catalfamo
iScience 2021
Sex-Specific Effects of Plastic Caging in Murine Viral Myocarditis
KA Bruno, LP Macomb, AC Morales-Lara, JE Mathews, JA Frisancho, AL Yang, DN Florio, BH Edenfield, ER Whelan, GR Salomon, AR Hill, CC Hewa-Rahinduwage, AJ Scott, HD Greyner, FA Molina, MS Greenaway, GM Cooper, DL Fairweather
International journal of molecular sciences 2021
PAR1 regulation of CXCL1 expression and neutrophil recruitment to the lung in mice infected with influenza A virus
S Antoniak, K Tatsumi, CM Schmedes, GJ Egnatz, AC Auriemma, V Bharathi, T Stokol, MA Beck, JH Griffin, JS Palumbo, N Mackman
Journal of Thrombosis and Haemostasis 2021
Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy
A Bhalerao, S Raut, B Noorani, S Mancuso, L Cucullo
Cells 2021
Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice
RC Gunther, V Bharathi, SD Miles, LR Tumey, CM Schmedes, K Tatsumi, MD Bridges, D Martinez, SA Montgomery, MA Beck, E Camerer, N Mackman, S Antoniak
Frontiers in immunology 2021
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
J Friebel, E Moritz, M Witkowski, K Jakobs, E Strässler, A Dörner, D Steffens, M Puccini, S Lammel, R Glauben, F Nowak, N Kränkel, A Haghikia, V Moos, HP Schutheiss, SB Felix, U Landmesser, BH Rauch, U Rauch
Cells 2021
Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability
R Lee, T Kawano, S Grover, V Bharathi, D Martinez, D Cowley, N Mackman, W Bergmeier, S Antoniak
Journal of Thrombosis and Haemostasis 2021
Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses
RB Kennedy, IH Haralambieva, IG Ovsyannikova, EA Voigt, BR Larrabee, DJ Schaid, MT Zimmermann, AL Oberg, GA Poland
Frontiers in immunology 2020
Coagulation and Fibrinolysis in Kidney Graft Rejection
G Stallone, P Pontrelli, F Rascio, G Castellano, L Gesualdo, G Grandaliano
Frontiers in immunology 2020
Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19
KL Hartshorn
Frontiers in Cellular and Infection Microbiology 2020
COVID-19 cytokine storm: the interplay between inflammation and coagulation
RJ Jose, A Manuel
The lancet. Respiratory medicine 2020
Antiviral anticoagulation
EL Pryzdial, MR Sutherland, BH Lin, M Horwitz
Research and Practice in Thrombosis and Haemostasis 2020
Proteinase‐activated receptor 1: A target for repurposing in the treatment of COVID‐19?
K Sriram, PA Insel
British Journal of Pharmacology 2020
Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis
RJ José, A Williams, A Manuel, JS Brown, RC Chambers
European Respiratory Review 2020
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs
JG Melgaço, DB e Cunha, T Azamor, AM da Silva, LN Tubarão, RB Gonçalves, RQ Monteiro, S Missailidis, PC da Costa Neves, AP Bom, C Cavaliere
Journal of Immunology Research 2020
Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19
AA Khan, RU Sany, S Islam, AB Islam
Frontiers in Genetics 2020
Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia
F Taus, G Salvagno, S Canè, C Fava, F Mazzaferri, E Carrara, V Petrova, RM Barouni, F Dima, A Dalbeni, S Romano, G Poli, M Benati, SD Nitto, G Mansueto, M Iezzi, E Tacconelli, G Lippi, V Bronte, P Minuz
Arteriosclerosis, thrombosis, and vascular biology 2020
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
KF Aliter, RA Al-Horani
Cardiovascular Drugs and Therapy 2020
Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
P Campana, V Parisi, D Leosco, D Bencivenga, FD Ragione, A Borriello
Cells 2020
Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases
JJ Posma, SP Grover, Y Hisada, AP Owens, S Antoniak, HM Spronk, N Mackman
Arteriosclerosis, thrombosis, and vascular biology 2019
Virus envelope tissue factor promotes infection in mice
MR Sutherland, AY Simon, I Shanina, MS Horwitz, W Ruf, EL Pryzdial
Journal of Thrombosis and Haemostasis 2019
Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection
K Tatsumi, CM Schmedes, ER Houston, E Butler, N Mackman, S Antoniak
Cellular Immunology 2019
BPA Alters Estrogen Receptor Expression in the Heart After Viral Infection Activating Cardiac Mast Cells and T Cells Leading to Perimyocarditis and Fibrosis
KA Bruno, JE Mathews, AL Yang, JA Frisancho, AJ Scott, HD Greyner, FA Molina, MS Greenaway, GM Cooper, A Bucek, AC Morales-Lara, AR Hill, AA Mease, DN Florio, JM Sousou, AC Coronado, AR Stafford, DL Fairweather
Frontiers in Endocrinology 2019
Cellular and Molecular Events in the Airway Epithelium Defining the Interaction Between House Dust Mite Group 1 Allergens and Innate Defences
J Zhang, J Chen, C Robinson
International journal of molecular sciences 2018
Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity
S Antoniak, K Tatsumi, CM Schmedes, SP Grover, R Pawlinski, N Mackman
Journal of Molecular and Cellular Cardiology 2018
The coagulation system in host defense
S Antoniak
Research and Practice in Thrombosis and Haemostasis 2018
Infectious myocarditis: the role of the cardiac vasculature
L Woudstra, LJ Juffermans, AC van Rossum, HW Niessen, PA Krijnen
Heart Failure Reviews 2018
A bronchoprotective role for Rgs2 in a murine model of lipopolysaccharide-induced airways inflammation
T George, M Chakraborty, MA Giembycz, R Newton
Allergy Asthma & Clinical Immunology 2018
Allergen Delivery Inhibitors: A Rationale for Targeting Sentinel Innate Immune Signaling of Group 1 House Dust Mite Allergens through Structure-Based Protease Inhibitor Design
J Zhang, J Chen, GK Newton, TR Perrior, C Robinson
Molecular pharmacology 2018
Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial
SJ Kent, S Hough, AD Kelleher, MG Law, J Hutchinson, M Catalfarmo, C Lane, JV Baker, S Emery
The Lancet HIV 2018
Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era
T He, E Falwell, E Brocca-Cofano, I Pandrea
Current Opinion in Virology 2017
Targeting PAR1: Now What?
R Flaumenhaft, KD Ceunynck
Trends in Pharmacological Sciences 2017
Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis
PM Becher, F Gotzhein, K Klingel, F Escher, S Blankenberg, D Westermann, D Lindner
Journal of Immunology Research 2017
Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections: PAR1 antagonist protects against RSV and hMPV infections
VB Lê, B Riteau, MC Alessi, C Couture, M Jandrot-Perrus, C Rhéaume, MÈ Hamelin, G Boivin
British Journal of Pharmacology 2017
Virus–Platelet Associations
Pryzdial EL, Lin BH, Sutherland MR
Platelets in Thrombotic and Non-Thrombotic Disorders 2017
HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver
Bi-Sen Ding, Catherine H. Liu, Yue Sun, Yutian Chen, Steven Swendeman, Bongnam Jung, Zhongwei cao, Deebly Chavez, Christina Christoffersen, Lars B. Nielsen, Susan Schwab, Shahin Rafii, Timothy Hla
JCI Insight 2016
Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice
S Antoniak, K Tatsumi, Y Hisada, JJ Milner, SD Neidich, CM Shaver, R Pawlinski, MA Beck, JA Bastarache, N Mackman
Journal of Thrombosis and Haemostasis 2016
Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12
AK Kopec, N Joshi, H Cline-Fedewa, AV Wojcicki, JL Ray, BP Sullivan, JE Froehlich, BF Johnson, MJ Flick, JP Luyendyk
Journal of Hepatology 2016
Innate immunity, hemostasis and matrix remodeling: PTX3 as a link
A Doni, C Garlanda, A Mantovani
Seminars in Immunology 2016
Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia
Y Yang, H Tang
Cellular and Molecular Immunology 2016
Respiratory Antiviral Immunity and Immunobiotics: Beneficial Effects on Inflammation-Coagulation Interaction during Influenza Virus Infection
H Zelaya, S Alvarez, H Kitazawa, J Villena
Frontiers in immunology 2016
Platelets and coagulation in infection
RP Davis, S Miller-Dorey, CN Jenne
IBMS BoneKEy 2016
Innate generation of thrombin and intracellular oxidants in airway epithelium by allergen Der p 1
J Zhang, J Chen, K Allen-Philbey, CP Baruhupolage, T Tachie-Menson, SC Mangat, DR Garrod, C Robinson
Journal of Allergy and Clinical Immunology 2016
Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation
S Antoniak, JC Cardenas, LJ Buczek, FC Church, N Mackman, R Pawlinski
Cardiology 2016
Anticoagulation increases alveolar hemorrhage in mice infected with influenza A
K Tatsumi, S Antoniak, S Subramaniam, B Gondouin, SD Neidich, MA Beck, J Mickelson, DM Monroe, JA Bastarache, N Mackman
Physiological Reports 2016
Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice
S Antoniak, K Tatsumi, M Bode, S Vanja, JC Williams, N Mackman
Journal of Innate Immunity 2016
Mapping of a quantitative trait locus controlling susceptibility to Coxsackievirus B3-induced viral hepatitis
SA Wiltshire, J Marton, GA Leiva-Torres, SM Vidal
Genes and Immunity 2015
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection
AC Hodowanec, RD Lee, KE Brady, W Gao, S Kincaid, J Plants, M Bahk, N Mackman, AL Landay, GD Huhn
BMC Infectious Diseases 2015
Glucose-6-Phosphate Dehydrogenase Enhances Antiviral Response through Downregulation of NADPH Sensor HSCARG and Upregulation of NF-κB Signaling
YH Wu, D Chiu, HR Lin, HY Tang, ML Cheng, HY Ho
Viruses 2015
Pulmonary C Fibers Modulate MMP-12 Production via PAR2 and Are Involved in the Long-Term Airway Inflammation and Airway Hyperresponsiveness Induced by Respiratory Syncytial Virus Infection
N Zang, J Zhuang, Y Deng, Z Yang, Z Ye, X Xie, L Ren, Z Fu, Z Luo, F Xu, E Liu, DS Lyles
Journal of virology 2015
Thrombin Inhibition with Dabigatran Protects against High-Fat Diet-Induced Fatty Liver Disease in Mice
AK Kopec, N Joshi, KL Towery, KM Kassel, BP Sullivan, MJ Flick, JP Luyendyk
The Journal of pharmacology and experimental therapeutics 2014
The Procoagulant Envelope Virus Surface: Contribution to Enhanced Infection
EL Pryzdial, MR Sutherland, W Ruf
Thrombosis Research 2014
Multiple roles of the coagulation protease cascade during virus infection
S Antoniak, N Mackman
Blood 2014
Roles of PAR1 and PAR2 in viral myocarditis
N Mackman, S Antoniak
Thrombosis Research 2014
Tissue factor, protease activated receptors and pathologic heart remodelling:
S Antoniak, E Sparkenbaugh, R Pawlinski
Thrombosis and Haemostasis 2014
Coagulation, Protease-Activated Receptors, and Viral Myocarditis
S Antoniak, N Mackman
Journal of Cardiovascular Translational Research 2013
Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model
L Aerts, MÈ Hamelin, C Rhéaume, S Lavigne, C Couture, W Kim, D Susan-Resiga, A Prat, NG Seidah, N Vergnolle, B Riteau, G Boivin
PloS one 2013
Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits
F Berri, VB Lê, M Jandrot-Perrus, B Lina, B Riteau
Cellular and Molecular Life Sciences 2013
Chronic HIV disease and activation of the coagulation system
JV Baker
Thrombosis Research 2013
Protease activated receptor-2 contributes to heart failure
S Antoniak, EM Sparkenbaugh, M Tencati, M Rojas, N Mackman, R Pawlinski
PloS one 2013
Cofactoring and Dimerization of Proteinase-Activated Receptors
H Lin, AP Liu, TH Smith, J Trejo
2013
Thrombin generation and atherosclerosis
J Kalz, H ten Cate, HM Spronk
Journal of Thrombosis and Thrombolysis 2013

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 8 X users
Referenced in 1 patents
On 1 Facebook pages
91 readers on Mendeley
1 readers on CiteULike
See more details